Abstract
This report is a detailed assessment of products and technologies in
orthopedic biomaterials under development and on the market, including bone
grafts (including allografts), bone graft substitutes, polymers, growth
factors, surgical glues and sealants, anti-adhesive products, and tissue
engineering products. The report addresses the major pathologies requiring
surgical intervention (e.g., trauma, degenerative diseases of hip, knee and
spine, etc); the most common and most important surgical procedures, with
caseload detailed globally and regionally; the range of products available and
their role in the various surgical procedures; trends in surgical practice,
especially as they affect product uptake; description of the range of product
types and specific products in current use; discussion of product trends,
including changing market expectations leading research towards new products;
and discussion of the main factors driving the market, and those inhibiting
growth; the regulatory environment and its evolution; market size and growth,
globally and regionally (USA, Europe, Japan, RoW) for 2006; market breakdown
by main product types; leading companies and their market shares; five-year
market forecasts (2007-11); and company profiles of the largest and/or most
important companies.